Monica Lynn Hollowell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Nodule | 8 | 2023 | 760 | 0.790 |
Why?
|
Thyroid Neoplasms | 9 | 2023 | 2332 | 0.570 |
Why?
|
Adenocarcinoma, Follicular | 4 | 2023 | 325 | 0.550 |
Why?
|
Odontogenic Tumors | 1 | 2010 | 45 | 0.340 |
Why?
|
Fibroma | 1 | 2010 | 190 | 0.310 |
Why?
|
Papilloma | 1 | 2007 | 141 | 0.280 |
Why?
|
Thyroid Gland | 4 | 2021 | 1168 | 0.240 |
Why?
|
Granuloma, Plasma Cell | 1 | 2024 | 80 | 0.220 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2022 | 29 | 0.210 |
Why?
|
Myofibromatosis | 1 | 2022 | 27 | 0.210 |
Why?
|
Hepatoblastoma | 1 | 2022 | 88 | 0.200 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2022 | 101 | 0.200 |
Why?
|
Uric Acid | 1 | 2008 | 806 | 0.200 |
Why?
|
Gynecomastia | 1 | 2022 | 87 | 0.190 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2021 | 67 | 0.190 |
Why?
|
Hashimoto Disease | 1 | 2022 | 105 | 0.190 |
Why?
|
Gout | 1 | 2008 | 620 | 0.180 |
Why?
|
Breast Neoplasms, Male | 1 | 2022 | 221 | 0.170 |
Why?
|
Protoporphyria, Erythropoietic | 1 | 2020 | 55 | 0.170 |
Why?
|
Cytodiagnosis | 2 | 2022 | 442 | 0.160 |
Why?
|
Thyroidectomy | 2 | 2021 | 902 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 349 | 0.150 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2018 | 60 | 0.150 |
Why?
|
Sentinel Surveillance | 1 | 2018 | 293 | 0.130 |
Why?
|
Leiomyomatosis | 1 | 2016 | 69 | 0.130 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2020 | 368 | 0.130 |
Why?
|
Smooth Muscle Tumor | 1 | 2016 | 63 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 707 | 0.130 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2007 | 2003 | 0.120 |
Why?
|
Tuberculosis, Pleural | 1 | 2014 | 13 | 0.120 |
Why?
|
Vascular Neoplasms | 1 | 2016 | 167 | 0.120 |
Why?
|
Soft Tissue Neoplasms | 1 | 2022 | 1152 | 0.110 |
Why?
|
Balloon Occlusion | 1 | 2014 | 127 | 0.110 |
Why?
|
Mastectomy | 1 | 2022 | 1832 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1596 | 0.110 |
Why?
|
Eustachian Tube | 1 | 2014 | 96 | 0.110 |
Why?
|
Chondroma | 1 | 2013 | 53 | 0.110 |
Why?
|
Otologic Surgical Procedures | 1 | 2014 | 149 | 0.110 |
Why?
|
Ear Diseases | 1 | 2014 | 177 | 0.100 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 785 | 0.100 |
Why?
|
Epiphyses | 1 | 2013 | 190 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 2418 | 0.100 |
Why?
|
Sarcoma | 1 | 2022 | 1786 | 0.100 |
Why?
|
Humerus | 1 | 2013 | 269 | 0.100 |
Why?
|
Incidental Findings | 3 | 2024 | 698 | 0.090 |
Why?
|
Biopsy, Fine-Needle | 3 | 2022 | 1110 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4490 | 0.080 |
Why?
|
Diagnosis, Differential | 5 | 2022 | 12965 | 0.080 |
Why?
|
Child | 12 | 2023 | 79806 | 0.080 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6465 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2016 | 2907 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4319 | 0.070 |
Why?
|
Proteins | 1 | 2021 | 6029 | 0.070 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2007 | 100 | 0.070 |
Why?
|
Colchicine | 1 | 2008 | 261 | 0.070 |
Why?
|
Ultrasonography | 1 | 2018 | 5961 | 0.060 |
Why?
|
Adolescent | 11 | 2023 | 87810 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3426 | 0.060 |
Why?
|
Biopsy | 3 | 2024 | 6771 | 0.060 |
Why?
|
Fever of Unknown Origin | 1 | 2024 | 94 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2022 | 40 | 0.050 |
Why?
|
Glypicans | 1 | 2022 | 33 | 0.050 |
Why?
|
Humans | 24 | 2024 | 760621 | 0.050 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2021 | 12 | 0.050 |
Why?
|
alpha-Fetoproteins | 1 | 2022 | 222 | 0.050 |
Why?
|
Ribonuclease III | 1 | 2023 | 279 | 0.050 |
Why?
|
Lip | 1 | 2022 | 197 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2013 | 2532 | 0.050 |
Why?
|
DEAD-box RNA Helicases | 1 | 2023 | 383 | 0.040 |
Why?
|
Tissue Banks | 1 | 2020 | 184 | 0.040 |
Why?
|
Child, Preschool | 5 | 2024 | 42063 | 0.040 |
Why?
|
Thyrotropin | 1 | 2022 | 832 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2282 | 0.040 |
Why?
|
Female | 13 | 2024 | 391270 | 0.040 |
Why?
|
Male | 13 | 2024 | 359744 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2018 | 573 | 0.040 |
Why?
|
Infant | 3 | 2022 | 36060 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13262 | 0.040 |
Why?
|
Syndrome | 1 | 2023 | 3280 | 0.030 |
Why?
|
Rare Diseases | 1 | 2021 | 619 | 0.030 |
Why?
|
Cytogenetic Analysis | 1 | 2016 | 271 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 80372 | 0.030 |
Why?
|
Self-Examination | 1 | 2013 | 71 | 0.030 |
Why?
|
Adult | 7 | 2023 | 219994 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2118 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2943 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 58741 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1895 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20509 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2145 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36290 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1166 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 4981 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22072 | 0.020 |
Why?
|
Heart Diseases | 1 | 2024 | 2809 | 0.020 |
Why?
|
Leiomyoma | 1 | 2016 | 654 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2803 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3486 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6315 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4107 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1266 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1180 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2295 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3618 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15289 | 0.020 |
Why?
|
Physical Examination | 1 | 2013 | 1244 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1296 | 0.020 |
Why?
|
Liver | 1 | 2022 | 7509 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1439 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13314 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29658 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3616 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 41335 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6068 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 5351 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9280 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9276 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4902 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2014 | 1903 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18416 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16546 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10756 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25942 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18137 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9411 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26181 | 0.010 |
Why?
|
Middle Aged | 3 | 2019 | 220352 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24123 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39261 | 0.010 |
Why?
|
Risk Factors | 1 | 2022 | 74359 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81208 | 0.010 |
Why?
|
Aged | 2 | 2016 | 169152 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54303 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 58995 | 0.010 |
Why?
|
Animals | 1 | 2020 | 167963 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2014 | 65017 | 0.000 |
Why?
|